{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:39:57Z","timestamp":1765888797618},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,7]]},"DOI":"10.7759\/cureus.21972","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T11:53:51Z","timestamp":1644234831000},"source":"Crossref","is-referenced-by-count":2,"title":["Spectrum of Dyslipidemias in Treatment-Na\u00efve Human Immunodeficiency Virus-Infected Patients Presenting to an HIV Clinic of a Tertiary Care Hospital"],"prefix":"10.7759","author":[{"given":"Sadaf","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadia","family":"Salman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehwish","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanullah","family":"Bhalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javeid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismat","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"National AIDS Control Programme. Publications. (2021). Accessed. December 19, 2021: https:\/\/nacp.gov.pk\/howwework\/publications.html."},{"key":"ref2","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. (2021). https.\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/AdultandAdolescentGL.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703273361304","article-title":"Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury","volume":"336","author":"Ridzon R","year":"1997","unstructured":"Ridzon R, Gallagher K, Ciesielski C, Ginsberg MB, Robertson BJ, Luo CC, DeMaria A Jr. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury. N Engl J Med. 1997, 336:919-22. 10.1056\/NEJM199703273361304","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328319edc0","article-title":"HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection","volume":"22","author":"Kared H","year":"2008","unstructured":"Kared H, Leli\u00e8vre JD, Donkova-Petrini V, et al.. HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection. AIDS. 2008, 22:2451-60. 10.1097\/QAD.0b013e328319edc0","journal-title":"AIDS"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.6.1490","article-title":"Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections","volume":"168","author":"Niu MT","year":"1993","unstructured":"Niu MT, Stein DS, Schnittman SM. Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections. J Infect Dis. 1993, 168:1490-501. 10.1093\/infdis\/168.6.1490","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-1-200101020-00010","article-title":"Diagnosis of primary HIV-1 infection","volume":"134","author":"Daar ES","year":"2001","unstructured":"Daar ES, Little S, Pitt J, et al.. Diagnosis of primary HIV-1 infection. Ann Intern Med. 2001, 134:25-9. 10.7326\/0003-4819-134-1-200101020-00010","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-021-00756-y","article-title":"Gradual increasing dyslipidemia in treatment-naive male patients with human immunodeficiency virus and treated with tenofovir plus lamivudine plus efavirenz for 3\u00a0years","volume":"13","author":"Liu D","year":"2021","unstructured":"Liu D, Zhang X, Kang J, Gao F, He Y, He S. Gradual increasing dyslipidemia in treatment-naive male patients with human immunodeficiency virus and treated with tenofovir plus lamivudine plus efavirenz for 3\u00a0years. Diabetol Metab Syndr. 2021, 13:135. 10.1186\/s13098-021-00756-y","journal-title":"Diabetol Metab Syndr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-236","article-title":"The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population","volume":"14","author":"Bekolo CE","year":"2014","unstructured":"Bekolo CE, Nguena MB, Ewane L, Bekoule PS, Kollo B. The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population. BMC Public Health. 2014, 14:236. 10.1186\/1471-2458-14-236","journal-title":"BMC Public Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-018-0411-2","article-title":"Inflammation and metabolic complications in HIV","volume":"15","author":"Bourgi K","year":"2018","unstructured":"Bourgi K, Wanjalla C, Koethe JR. Inflammation and metabolic complications in HIV. Curr HIV\/AIDS Rep. 2018, 15:371-81. 10.1007\/s11904-018-0411-2","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/0956462418775188","article-title":"Metabolic syndrome in human immunodeficiency virus-infected patients","volume":"29","author":"Duro M","year":"2018","unstructured":"Duro M, Manso MC, Barreira S, Rebelo I, Medeiros R, Almeida C. Metabolic syndrome in human immunodeficiency virus-infected patients. Int J STD AIDS. 2018, 29:1089-97. 10.1177\/0956462418775188","journal-title":"Int J STD AIDS"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195942","article-title":"Malnutrition and lipid abnormalities in antiretroviral na\u00efve HIV-infected adults in Addis Ababa: a cross-sectional study","volume":"13","author":"Adal M","year":"2018","unstructured":"Adal M, Howe R, Kassa D, Aseffa A, Petros B. Malnutrition and lipid abnormalities in antiretroviral na\u00efve HIV-infected adults in Addis Ababa: a cross-sectional study. PLoS One. 2018, 13:e0195942. 10.1371\/journal.pone.0195942","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ramb.2012.11.003","article-title":"Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review","volume":"59","author":"Souza SJ","year":"2013","unstructured":"Souza SJ, Luzia LA, Santos SS, Rond\u00f3 PH. Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review. Rev Assoc Med Bras (1992). 2013, 59:186-98. 10.1016\/j.ramb.2012.11.003","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-05787-4","article-title":"Consistent use of lipid lowering therapy in HIV infection is associated with low mortality","volume":"21","author":"Drechsler H","year":"2021","unstructured":"Drechsler H, Ayers C, Cutrell J, Arasaratnam R, Bedimo R. Consistent use of lipid lowering therapy in HIV infection is associated with low mortality. BMC Infect Dis. 2021, 21:150. 10.1186\/s12879-021-05787-4","journal-title":"BMC Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.769740","article-title":"Influence of statin therapy on the incidence of cardiovascular events, cancer, and all-cause mortality in people living with HIV: a meta-analysis","volume":"8","author":"Li Y","year":"2021","unstructured":"Li Y, Wang Z, Xia H, Zhang J. Influence of statin therapy on the incidence of cardiovascular events, cancer, and all-cause mortality in people living with HIV: a meta-analysis. Front Med (Lausanne). 2021, 8:769740. 10.3389\/fmed.2021.769740","journal-title":"Front Med (Lausanne)"},{"key":"ref15","article-title":"Summary of notifiable diseases--United States, 2003","volume":"52","author":"Hopkins RS","year":"2005","unstructured":"Hopkins RS, Jajosky RA, Hall PA, et al.. Summary of notifiable diseases--United States, 2003. MMWR Morb Mortal Wkly Rep. 2005, 52:1-85.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065126","article-title":"Lipid peroxidation and total cholesterol in HAART-na\u00efve patients infected with circulating recombinant forms of human immunodeficiency virus type-1 in Cameroon","volume":"8","author":"Teto G","year":"2013","unstructured":"Teto G, Kanmogne GD, Torimiro JN, et al.. Lipid peroxidation and total cholesterol in HAART-na\u00efve patients infected with circulating recombinant forms of human immunodeficiency virus type-1 in Cameroon. PLoS One. 2013, 8:e65126. 10.1371\/journal.pone.0065126","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e328344556e","article-title":"Dyslipidemia and lipid management in HIV-infected patients","volume":"18","author":"Lo J","year":"2011","unstructured":"Lo J. Dyslipidemia and lipid management in HIV-infected patients. Curr Opin Endocrinol Diabetes Obes. 2011, 18:144-7. 10.1097\/MED.0b013e328344556e","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/15284336.2017.1311502","article-title":"Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment","volume":"18","author":"Calza L","year":"2017","unstructured":"Calza L, Colangeli V, Magistrelli E, et al.. Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment. HIV Clin Trials. 2017, 18:110-7. 10.1080\/15284336.2017.1311502","journal-title":"HIV Clin Trials"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/1596-3519.108246","article-title":"Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians","volume":"12","author":"Muhammad S","year":"2013","unstructured":"Muhammad S, Sani MU, Okeahialam BN. Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians. Ann Afr Med. 2013, 12:24-8. 10.4103\/1596-3519.108246","journal-title":"Ann Afr Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2626-z","article-title":"Cardiovascular risk and dyslipidemia among persons living with HIV: a review","volume":"17","author":"Maggi P","year":"2017","unstructured":"Maggi P, Di Biagio A, Rusconi S, et al.. Cardiovascular risk and dyslipidemia among persons living with HIV: a review. BMC Infect Dis. 2017, 17:551. 10.1186\/s12879-017-2626-z","journal-title":"BMC Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/83006-spectrum-of-dyslipidemias-in-treatment-nave-human-immunodeficiency-virus-infected-patients-presenting-to-an-hiv-clinic-of-a-tertiary-care-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:24Z","timestamp":1707507864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/83006-spectrum-of-dyslipidemias-in-treatment-nave-human-immunodeficiency-virus-infected-patients-presenting-to-an-hiv-clinic-of-a-tertiary-care-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.21972","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,7]]}}}